LPI (LP Information)' newest research report, the ﾓPoint of Care Testing for Infectious Disease Industry Forecastﾔ looks at past sales and reviews total world Point of Care Testing for Infectious Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Point of Care Testing for Infectious Disease sales for 2023 through 2029. With Point of Care Testing for Infectious Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point of Care Testing for Infectious Disease industry. This Insight Report provides a comprehensive analysis of the global Point of Care Testing for Infectious Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point of Care Testing for Infectious Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firmsﾒ unique position in an accelerating global Point of Care Testing for Infectious Disease market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point of Care Testing for Infectious Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point of Care Testing for Infectious Disease. The global Point of Care Testing for Infectious Disease market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Point of Care Testing for Infectious Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Point of Care Testing for Infectious Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Point of Care Testing for Infectious Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Point of Care Testing for Infectious Disease players cover Abbott, Roche, Siemens, Danaher, Becton, Dickinson, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics and Quidel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. This report presents a comprehensive overview, market shares, and growth opportunities of Point of Care Testing for Infectious Disease market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Immunological Test Pathogen Nucleic Acid Test Segmentation by application Hospital Clinics Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Abbott Roche Siemens Danaher Becton, Dickinson Johnson & Johnson Instrumentation Laboratory PTS Diagnostics Quidel Sekisui Diagnostics Nova EKF Diagnostics AccuBioTech Trinity Biotech
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Point of Care Testing for Infectious Disease Market Size 20
